Table of Content

1 Markets
1.1 Market Outlook
1.1.1 Product Definition
1.1.2 Inclusion and Exclusion Criteria
1.1.3 Key Findings
1.2 Industry Outlook
1.2.1 Market Overview
1.2.1.1 Timeline of Emerging Technologies for Infectious Disease Diagnostics
1.2.1.2 Advantages and Limitations of Emerging Infectious Disease Diagnostic Technologies
1.2.1.3 Advantages and Limitations of Point-of-Care Emerging Infectious Disease Diagnostics
1.2.1.4 Current Market Landscape of Emerging Infectious Disease Diagnostics
1.2.1.5 Future Potential
1.2.1.5.1 CRISPR
1.2.1.5.2 NGS
1.2.1.5.3 INAAT
1.2.1.5.4 Digital PCR (dPCR)
1.2.2 Patent Analysis
1.2.2.1 By Year
1.2.2.2 By Country/Organization
1.2.3 Pipeline Analysis
1.2.4 Impact of COVID-19 on Infectious Disease Diagnostics
1.2.4.1 Post-COVID-19 Scenario: A Paradigm Shift to Home-Based Testing
1.2.5 Supply Chain Analysis
1.3 Market Dynamics
1.3.1 Impact Analysis
1.3.2 Drivers
1.3.2.1 Economic Burden of Infectious Diseases
1.3.2.2 Government Support to Advance Research and Facilitate Early Diagnosis of Infectious Diseases Through Funding and Collaboration
1.3.2.3 Increasing Demand for Point-of-Care (POC) and Syndromic Testing
1.3.2.4 Technological Advancements in Molecular Diagnostics
1.3.2.4.1 Isothermal Nucleic Acid Amplification Techniques (INAATs)
1.3.2.4.2 Digital PCR
1.3.2.4.3 CRISPR Technologies
1.3.3 Restraints
1.3.3.1 Poor Reimbursement for Molecular Diagnostic Tests for Infectious Diseases
1.3.3.2 Erratic Trend in Infectious Disease Epidemic Outbreaks Globally
1.3.3.3 Lack of an Established Framework for NGS-based Tests for Infectious Diseases
1.3.4 Opportunities
1.3.4.1 Potential of Molecular Diagnostic Tests in Low-Resource Settings
1.3.4.2 Potential of Rapid Point-of-Care Tests in Managing Antimicrobial Resistance

2 Asia-Pacific
2.1 Asia-Pacific Emerging Infectious Disease Diagnostics Market
2.1.1 Regulatory Framework
2.1.2 Market Dynamics
2.1.2.1 Impact Analysis
2.1.3 Market Size and Forecast
2.1.3.1 Asia-Pacific Emerging Infectious Disease Diagnostics Market (by Application)
2.1.3.2 Asia-Pacific Emerging Infectious Disease Diagnostics Market (by Technology)
2.1.3.3 Asia-Pacific Emerging Infectious Disease Diagnostics Market (by Type of Infection)
2.1.3.4 Asia-Pacific Emerging Infectious Disease Diagnostics Market (by Disease Type)
2.1.3.5 Asia-Pacific Emerging Infectious Disease Diagnostics Market (by End User)
2.1.3.6 Asia-Pacific Emerging Infectious Disease Diagnostics Market (by Country)
2.1.3.6.1 Japan
2.1.3.6.1.1 Market Dynamics
2.1.3.6.1.2 Market Size and Forecast
2.1.3.6.1.2.1 Japan Emerging Infectious Disease Diagnostics Market (by End User)
2.1.3.6.2 China
2.1.3.6.2.1 Market Dynamics
2.1.3.6.2.2 Market Size and Forecast
2.1.3.6.2.2.1 China Emerging Infectious Disease Diagnostics Market (by End User)
2.1.3.6.3 Australia
2.1.3.6.3.1 Market Dynamics
2.1.3.6.3.2 Market Size and Forecast
2.1.3.6.3.2.1 Australia Emerging Infectious Disease Diagnostics Market (by End User)
2.1.3.6.4 South Korea
2.1.3.6.4.1 Market Dynamics
2.1.3.6.4.2 Market Size and Forecast
2.1.3.6.4.2.1 South Korea Emerging Infectious Disease Diagnostics Market (by End User)
2.1.3.6.5 India
2.1.3.6.5.1 Market Dynamics
2.1.3.6.5.2 Market Size and Forecast
2.1.3.6.5.2.1 India Emerging Infectious Disease Diagnostics Market (by End User)
2.1.3.6.6 Rest-of-Asia-Pacific
2.1.3.6.6.1 Market Dynamics
2.1.3.6.6.2 Market Size and Forecast
2.1.3.6.6.2.1 Rest-of-Asia-Pacific Emerging Infectious Disease Diagnostics Market (by End User)

3 Markets - Competitive Benchmarking & Company Profiles
3.1 Competitive Landscape
3.1.1 Overview
3.1.2 Corporate Strategies
3.1.2.1 Mergers and Acquisitions
3.1.2.2 Synergistic Activities
3.1.2.3 Business Expansions and Funding
3.1.3 Business Strategies
3.1.3.1 Product Launches/Upgradations/Approvals
3.2 Market Share Analysis
3.3 Emerging Infectious Disease Diagnostics Ecosystem Active Players
3.4 Company Profiles
3.5 Company Snapshots
3.5.1 CrisprBits
3.5.1.1 Company Overview
3.5.1.2 Role of CrisprBits in the Emerging Infectious Disease Diagnostics Market
3.5.1.3 Key Developments
List of Figures
Figure 1: History of Infectious Disease Outbreaks Globally
Figure 2: Number of Infectious Disease Outbreaks per Year Reported by the WHO, Estimates
Figure 3: Emerging Infectious Disease Diagnostics Market (by Technology), $Billion, 2022-2033
Figure 4: Emerging Infectious Disease Diagnostics Market, Impact Analysis
Figure 5: Emerging Infectious Disease Diagnostics Market (by Technology), Share (%), 2022 and 2033
Figure 6: Emerging Infectious Disease Diagnostics Market (by Application), Share (%), 2022 and 2033
Figure 7: Share of Key Developments, January 2019-June 2023
Figure 8: Emerging Infectious Disease Diagnostics Market (by Region), $Billion, 2022 and 2033
Figure 9: Market Share Analysis for Emerging Infectious Disease Diagnostics Market (by Company), 2022
Figure 10: Key Insights Validated from Primary Interviews
Figure 11: Emerging Infectious Disease Diagnostics Market Segmentation
Figure 12: Emerging Infectious Disease Diagnostics Market Research Methodology
Figure 13: Primary Research Methodology
Figure 14: Bottom-Up Approach (Segment-Wise Analysis)
Figure 15: Top-Down Approach (Segment-Wise Analysis)
Figure 16: Timeline of Emerging Technologies for Infectious Disease Diagnostics
Figure 17: Advantages of Emerging Infectious Disease Diagnostic Technologies
Figure 18: Limitations of Emerging Infectious Disease Diagnostic Technologies
Figure 19: Key Settings of POC Testing Deployment
Figure 20: Key Challenges Associated with Point-of-Care Testing
Figure 21: Emerging Infectious Disease Diagnostics Market (by Technology), $Billion, 2022-2033
Figure 22: Future Potential of NGS in Infectious Disease Diagnostics
Figure 23: Number of Molecular Diagnostics Patents for Infectious Diseases (by Year)
Figure 24: Number of Molecular Diagnostic Patents for Infectious Diseases (by Country/Organization)
Figure 25: Key Benefits of Home-Based Testing
Figure 26: Typical Supply Chain for a Diagnostic Test
Figure 27: Emerging Infectious Disease Diagnostics Market, Impact Analysis
Figure 28: Fiscal Response to the COVID-19 Pandemic (% of GDP)
Figure 29: Advantages of Point-of-Care Tests in Molecular Diagnostics
Figure 30: Key Clinical Areas Demanding Commercial Availability of Syndromic Tests
Figure 31: Advantages of INAAT over PCR
Figure 32: Number of LAMP Publications on Public Databases, 2016-2022
Figure 33: Number of INAAT Publications on Public Databases, 2016-2022
Figure 34: Advantages of Digital PCR over Quantitative Real-Time PCR
Figure 35: Number of “Digital PCR” Publications on Public Databases, 2016-2022
Figure 36: Notable Outbreaks of Infectious Diseases in Humans (by Region)
Figure 37: Number of Infectious Disease Outbreaks per Year Reported by the WHO, Estimates
Figure 38: Asia-Pacific Emerging Infectious Disease Diagnostics Market, $Billion, 2022-2033
Figure 39: Asia-Pacific Emerging Infectious Disease Diagnostics Market (by Application), $Billion, 2022-2033
Figure 40: Asia-Pacific Emerging Infectious Disease Diagnostics Market (by Technology), $Billion, 2022-2033
Figure 41: Asia-Pacific Emerging Infectious Disease Diagnostics Market (by Type of Infection), $Billion, 2022-2033
Figure 42: Asia-Pacific Emerging Infectious Disease Diagnostics Market (by Disease Type), $Billion, 2022-2033
Figure 43: Asia-Pacific Emerging Infectious Disease Diagnostics Market (by End User), $Billion, 2022-2033
Figure 44: Asia-Pacific Emerging Infectious Disease Diagnostics Market (by Country), % Share, 2022 and 2033
Figure 45: Japan Emerging Infectious Disease Diagnostics Market, $Billion, 2022-2033
Figure 46: Japan Emerging Infectious Disease Diagnostics Market (by End User), $Billion, 2022-2033
Figure 47: China Emerging Infectious Disease Diagnostics Market, $Billion, 2022-2033
Figure 48: China Emerging Infectious Disease Diagnostics Market (by End User), $Billion, 2022-2033
Figure 49: Australia Emerging Infectious Disease Diagnostics Market, $Billion, 2022-2033
Figure 50: Australia Emerging Infectious Disease Diagnostics Market (by End User), $Million, 2022-2033
Figure 51: South Korea Emerging Infectious Disease Diagnostics Market, $Billion, 2022-2033
Figure 52: South Korea Emerging Infectious Disease Diagnostics Market (by End User), $Million, 2022-2033
Figure 53: India Emerging Infectious Disease Diagnostics Market, $Billion, 2022-2033
Figure 54: India Emerging Infectious Disease Diagnostics Market (by End User), $Million, 2022-2033
Figure 55: Rest-of-Asia-Pacific Emerging Infectious Disease Diagnostics Market, $Billion, 2022-2033
Figure 56: Rest-of-Asia-Pacific Emerging Infectious Disease Diagnostics Market (by End User), $Million, 2022-2033
Figure 57: Share of Key Developments, January 2019-June 2023
Figure 58: Number of Mergers and Acquisitions (by Company), January 2019-June 2023
Figure 59: Share of Synergistic Activities (by Company), January 2019-June 2023
Figure 60: Number of Business Expansions and Funding Activities (by Company), January 2019-June 2023
Figure 61: Number of Product Launches/Upgradations/Approvals (by Company), January 2019-June 2023
Figure 62: Market Share Analysis for Emerging Infectious Disease Diagnostics Market (by Company), 2022
Figure 63: Emerging Infectious Disease Diagnostics Market, Total Number of Companies Profiled
Figure 64: CrisprBits: Overall Product Portfolio
List of Tables
Table 1: Some of the Key Developments By Companies Leveraging Emerging Technologies in Infectious Disease Diagnostics
Table 2: Key Product Offerings by Players in the Emerging Infectious Disease Diagnostics Market
Table 3: Key Questions Answered in the Report
Table 4: Some of the RT-LAMP Assays Developed during COVID-19
Table 5: Molecular Diagnostic Products for Infectious Diseases Under Development
Table 6: At-Home COVID-19 Kits Approved for Commercial Use by ICMR
Table 7: Disease Burden for Infectious Diseases (DALY), , Million, 2019
Table 8: Key Initiatives by Governments Globally
Table 9: Examples of International Research Consortiums for Managing Response to Infectious Diseases
Table 10: List of Infectious Disease Outbreaks (by Region and Year)
Table 11: Asia-Pacific Emerging Infectious Disease Diagnostics Market, Impact Analysis
Table 12: Emerging Infectious Disease Diagnostics Market, Key Active Players